Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15 USD | -0.20% | +1.83% | +11.86% |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ulrik Nielsen
FOU | Founder | 52 | 31/12/92 |
Gary Crocker
CEO | Chief Executive Officer | 72 | 31/12/03 |
Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Crocker
CEO | Chief Executive Officer | 72 | 31/12/03 |
Director/Board Member | 45 | 18/09/19 | |
Ulrik Nielsen
FOU | Founder | 52 | 31/12/92 |
Director/Board Member | 46 | 18/09/19 | |
Ana Radeljevic
BRD | Director/Board Member | 44 | 05/06/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,531,760 | 14,355,601 ( 98.79 %) | 0 | 98.79 % |
Company contact information
Merrimack Pharmaceuticals, Inc.
One Broadway 14th Floor
02142, Cambridge
+
http://www.merrimackpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+11.86% | 218M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- MACK Stock
- Company Merrimack Pharmaceuticals, Inc.